Greenblatt, D. J., & Harmatz, J. S. (2015). Ritonavir is the best alternative to ketoconazole as an index inhibitor of cytochrome P450-3A in drug–drug interaction studies. Br J Clin Pharmacol.
Chicago Style citaatGreenblatt, David J., en Jerold S. Harmatz. "Ritonavir Is the Best Alternative to Ketoconazole As an Index Inhibitor of Cytochrome P450-3A in Drug–drug Interaction Studies." Br J Clin Pharmacol 2015.
MLA citatieGreenblatt, David J., en Jerold S. Harmatz. "Ritonavir Is the Best Alternative to Ketoconazole As an Index Inhibitor of Cytochrome P450-3A in Drug–drug Interaction Studies." Br J Clin Pharmacol 2015.
Let op: Deze citaties zijn niet altijd 100% accuraat.